PTC Therapeutics, Huntington's Disease and Fast Track
PTC Therapeutics' Huntington's Treatment Gets FDA Fast Track Designation
PTC Therapeutics' treatment for Huntington's disease has received a fast track designation from U.S. health regulators. The biopharmaceutical company said Thursday that the Food and Drug Administration granted the designation to the PTC518 program which aims to reduce the production of mutated Huntington protein.
FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program
PTC Therapeutics (NASDAQ: PTCT) announced today that the FDA has granted Fast Track designation to the PTC518 program for the treatment of Huntington's disease. Fast Track designation is awarded to promising therapies for diseases of high unmet need.
Potential Tropical Cyclone 9 could become a landfalling major hurricane for the Florida Gulf Coast on Thursday.
We have no weather worries in the short term, but the forecast is looking more active for the middle and end of the week as ...
The National Hurricane Center has issued tropical storm watches for much of Central Florida, as of 5 a.m on Tuesday.
Since it's expected to strengthen, tropical storm warnings are in effect for both the North and South Carolina Coast. Coastal flooding, 1-3 foot storm surge and heavy rainfall will impact areas ...
Potential Tropical Cyclone 9 continues to organize in the northwest Caribbean sea this morning, and is expected to develop into Tropical Storm Helene later today. Helene will strengthen into a ...
Purchasing an iPhone has never been easier, thanks to Blinkit, a quick commerce platform that has launched its lightning-fast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback